AdaptHealth 2025 Q3 Earnings Net Income Surges 7.5% as Revenue Beats Estimates

AdaptHealth (AHCO) reported third-quarter 2025 results exceeding revenue expectations while reaffirming full-year guidance. , driven by organic growth across all segments. , aligning with guidance, .

Revenue

, , supported by strong demand for sleep therapy equipment. , bolstered by oxygen and ventilation services, . , despite asset divestitures, reflecting resilience in orthotics and hospice services.

Earnings/Net Income

The company’s profitability strengthened, . , underscoring operational efficiency and disciplined cost management.

Post-Earnings Price Action Review



, . The sharp post-earnings rebound reflects investor confidence in the company’s operational turnaround and debt reduction progress.

CEO Commentary

CEO highlighted Q3 as a “milestone quarter,” emphasizing operational improvements, , and progress toward a 2.50x net leverage target. Strategic initiatives, , underscored the company’s focus on sustainable value creation.

Guidance

AdaptHealth maintained 2025 guidance, . The company anticipates 6–8% revenue growth in 2026, driven by capitated contracts and operational efficiencies, while maintaining a net leverage ratio below 2.50x.

Additional News

Recent developments include the acquisition of two HME providers and the disposal of non-core Wellness at Home assets, enhancing portfolio focus. The company also secured a capitated agreement for 170,000 members, signaling strategic growth in managed care. Additionally, , reflecting digital engagement gains.

Key Takeaways

AdaptHealth’s Q3 performance highlights its ability to navigate economic challenges through operational discipline and strategic pivots. While revenue growth moderated from prior years, the company’s focus on debt reduction, digital transformation, and capitated contracts positions it for long-term resilience. Investors will closely monitor progress toward net leverage targets and the scalability of its new partnerships.